Skip to main content
Premium Trial:

Request an Annual Quote

TriLink, Biofortuna Ink New Licensing Deal for CleanAmp

NEW YORK (GenomeWeb News) – Trilink BioTechnologies said today that it has inked a new licensing agreement with Biofortuna allowing the UK firm to use Trilink's hot start deoxynucleotides for freeze-drying molecular diagnostic kit development and production service.

Biofortuna offers this product to "diagnostic companies looking to develop stabilized molecular diagnostic kits," said Mike Bunce, chief science officer of Biofortuna, in a statement.

This agreement is an extension of one signed in 2010 that permitted Biofortuna to use these deoxynucleotides in their own molecular diagnostics kits. The lyophilized kits, called SSPGo, are distributed exclusively by Abbott Molecular and contain buffers, primers, as well as Taq polymerase, and are stable for more than a year at temperatures up to 37°C.

Incorporation of TriLink's CleanAmp dNTPS allows the freeze dried kits to be hot start, meaning DNA polymerase remains inactive below a threshold temperature, which enhances detection of low concentrations of template DNA.

The companies will co-host a corporate workshop on freeze dried hot start PCR mixes at the Association of Molecular Pathology annual meeting being held next week in Phoenix Ariz.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.